Sandra Goble - Concepedia

Author

Sandra Goble

Clovis Oncology (United States)

Also Known As

S Goble, S. Goble, Sandra Goble, Sandra M. Goble

120

Publications

6.7K

Citations

H-Index

Concepts

All Affiliations

Clovis Oncology (United States)Vall d'Hebron Hospital Universitari Princess Margaret Cancer Centre Vall d'Hebron Institute of Oncology University Health Network

About

Sandra Goble is an author at Clovis Oncology (United States) specializing in medicine, ovarian cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	3.4K
2	Obstetrics	8	8	2K
3	Health Sciences	5	5	131
4	Molecular Medicine	2	2	57
5	Social Sciences	1	1	40

Sandra Goble

Publications

6.6K

Citations

H-Index

Page 1

	Year	Citations
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial Robert L. Coleman, Amit M. Oza, Domenica Lorusso, The Lancet Rucaparib Maintenance TreatmentMedicineRecurrent Ovarian CarcinomaGynecologyCancer Treatment	2017	1.7K
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial Elizabeth M. Swisher, Kevin Lin, Amit M. Oza, The Lancet Oncology MedicinePharmacologyPathologyCancer TreatmentOncology	2016	1.2K
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45) Bradley J. Monk, Christine Parkinson, Myong Cheol Lim, Journal of Clinical Oncology	2022	346
Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2 Amit M. Oza, Anna V. Tinker, Ana Oaknin, Gynecologic Oncology	2017	272
A Phase I–II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline <i>BRCA1/2</i> -Mutated Ovarian Carcinoma or Other Solid Tumors Rebecca Kristeleit, Geoffrey I. Shapiro, Howard A. Burris, Clinical Cancer Research	2017	236
Genitourinary Injuries in Pelvic Fracture Morbidity and Mortality Using the National Trauma Data Bank Marc A. Bjurlin, Richard J Fantus, Michele M. Mellett, The Journal of Trauma: Injury, Infection, and Critical Care	2009	223
The Trauma Quality Improvement Program of the American College of Surgeons Committee on Trauma Shahid Shafi, Avery B. Nathens, Gill H. Cryer, Journal of the American College of Surgeons	2009	203
The Trauma Quality Improvement Program: Pilot Study and Initial Demonstration of Feasibility Mark R. Hemmila, Avery B. Nathens, Shahid Shafi, The Journal of Trauma: Injury, Infection, and Critical Care	2010	193
Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2) Elizabeth M. Swisher, Tanya T. Kwan, Amit M. Oza, Nature Communications	2021	193
Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious <i>BRCA</i> Mutation Rachna T. Shroff, Andrew Hendifar, Robert R. McWilliams, JCO Precision Oncology	2018	173

Page 1